Invention Grant
- Patent Title: Antibodies against HER3
- Patent Title (中): 针对HER3的抗体
-
Application No.: US14116562Application Date: 2012-05-11
-
Publication No.: US09346883B2Publication Date: 2016-05-24
- Inventor: Abdelhakim Kharrat , Olivier Dubreuil , Yassamine Lazrek , Philippe Mondon , Khalil Bouayadi , Thierry Chardes , Andre Pelegrin , Christel Larbouret , Nadege A. Gaborit
- Applicant: Abdelhakim Kharrat , Olivier Dubreuil , Yassamine Lazrek , Philippe Mondon , Khalil Bouayadi , Thierry Chardes , Andre Pelegrin , Christel Larbouret , Nadege A. Gaborit
- Applicant Address: FR Paris FR Toulouse Cedex 1
- Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),Gamamabs Pharma SA
- Current Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),Gamamabs Pharma SA
- Current Assignee Address: FR Paris FR Toulouse Cedex 1
- Agency: Whitham, Curtis, Christofferson & Cook, P.C.
- Priority: EP11305583 20110513
- International Application: PCT/EP2012/058769 WO 20120511
- International Announcement: WO2012/156309 WO 20121122
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C07K16/28 ; C07K16/32
Abstract:
The invention relates to antibodies against HER3 and their use in the treatment of cancer.
Public/Granted literature
- US20140141019A1 ANTIBODIES AGAINST HER3 Public/Granted day:2014-05-22
Information query
